{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:13:32Z","timestamp":1787973212235,"version":"build-2784847793"},"reference-count":68,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Between 2015 and 2018, there were over 40 000 opioid-related overdose events and 4551 deaths among residents in British Columbia (BC). During this time the province mobilised a variety of policy levers to encourage physicians to expand access to opioid agonist treatment and the College of Physicians and Surgeons of British Columbia (CPSBC) released a practice standard establishing legally enforceable minimum thresholds of professional behaviour in the hopes of curtailing overdose events. Our goal is to conduct a comprehensive investigation of the intended and unintended consequences of these policy changes. Specifically, we aim to understand the effects of these measures on physician prescribing behaviours, identify physician characteristics associated with uptake of the new measures, and measure the effects of the policy changes on patients\u2019 access to quality primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a population-level, retrospective cohort study of all BC primary care physicians who prescribed any opioid medication for opioid-use disorder or chronic non-cancer pain during the study period, and their patients. The study period is 1 January 2013\u201331 December 2018, with a 1-year wash-in period (1 January 2012\u201331 December 2012) to exclude patients who initiated long-term opioid treatment prior to our study period or whose pain type (ie, \u2018chronic non-cancer\u2019, \u2018acute\u2019, \u2018cancer or palliative\u2019, or \u2018other\u2019) cannot be confirmed. The project combines five administrative health datasets under the authority of the BC Ministry of Health, with the CPSBC\u2019s Physician Registry, BC Cancer Agency\u2019s Cancer Registry and Vital Statistics\u2019 Mortality data. We will create measures of prescribing concordance, access, continuity, and comprehensiveness to assess primary care delivery and quality at both the physician and patient level. We will use generalised estimating equations, interrupted time series, mixed effects models, and funnel plots to identify factors related to changes in prescribing and evaluate the impact of the changes to prescribing policies. Results will be reported using appropriate Enhancing the QUAlity and Transparency Of health Research guidelines (eg, STrengthening the Reporting of OBservational studies in Epidemiology).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study has been approved by McGill University\u2019s Institutional Review Board (#A11-M55-19A), and the University of British Columbia\u2019s Research Ethics Board (#H19-03537). We will disseminate results via a combination of open access peer-reviewed journal publications, conferences, lay summaries and OpEds.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-038724","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T16:07:07Z","timestamp":1604592427000},"page":"e038724","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the intended and unintended consequences of opioid-prescribing interventions on primary care in British Columbia, Canada: protocol for a retrospective population-based cohort study"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-3634","authenticated-orcid":false,"given":"Dimitra","family":"Panagiotoglou","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-0364","authenticated-orcid":false,"given":"Rita","family":"McCracken","sequence":"additional","affiliation":[{"name":"Department of Family Practice, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4205-4600","authenticated-orcid":false,"given":"M Ruth","family":"Lavergne","sequence":"additional","affiliation":[{"name":"Centre for Applied Research in Mental Health and Addiction, Simon Fraser University, Burnaby, British Columbia, Canada"},{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin C","family":"Strumpf","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Economics, McGill University, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada"},{"name":"Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"},{"name":"Institute for Mental Health Policy Research, Centre for Addiction and Mental, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austyn","family":"Brackett","sequence":"additional","affiliation":[{"name":"Patient Voices Network, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyenne","family":"Johnson","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada"},{"name":"School of Nursing, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Kendall","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"2025120519531241000_10.11.e038724.1","unstructured":"Special Advisory Committee on the Epidemic of Opioid Overdoses . National report: apparent opioid-related deaths in Canada (January 2016 to December 2018). Ottawa: Public Health Agency of Canada, 2019."},{"key":"2025120519531241000_10.11.e038724.2","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.38.6.02"},{"key":"2025120519531241000_10.11.e038724.3","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.38.6.05"},{"key":"2025120519531241000_10.11.e038724.4","article-title":"Chronic disease prevention in Canada editorial. correction: at-a-glance - Impact of drug overdose-related deaths on life expectancy at birth in British Columbia","volume":"39","author":"Health","year":"2019","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"2025120519531241000_10.11.e038724.5","unstructured":"Vancouver Police Department . The opioid crisis: the need for treatment on demand. Vancouver Police Department, 2017."},{"key":"2025120519531241000_10.11.e038724.6","unstructured":"Vancouver Coastal Health . Response to the opioid overdose crisis in Vancouver coastal health. Vancouver, BC: Vancouver Coastal Health, 2019."},{"key":"2025120519531241000_10.11.e038724.7","unstructured":"Adams E et al . A guideline for the clinical management: opioid use disorder. Vancouver, BC: BC Centre for Substance Use, 2017."},{"key":"2025120519531241000_10.11.e038724.8","unstructured":"Dr. Bill . 5\u2019addiction medicine fee codes\u2019 available in BC, 2018."},{"key":"2025120519531241000_10.11.e038724.9","unstructured":"Doctors of BC . New fees, updated guidelines support treatment of opioid use disorder. Doctors of BC, 2018."},{"key":"2025120519531241000_10.11.e038724.10","unstructured":"British Columbia Centre on Substance Use . Provincial opioid addiction treatment support program. Vancouver, BC: British Columbia Centre on Substance Use, 2016."},{"key":"2025120519531241000_10.11.e038724.11","unstructured":"College of Physicians and Surgeons of British Columbia . Safe prescribing of drugs with potential for Misuse\/Diversion. College of Physicians and Surgeons BC, 2016."},{"key":"2025120519531241000_10.11.e038724.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30430-1"},{"key":"2025120519531241000_10.11.e038724.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18472"},{"key":"2025120519531241000_10.11.e038724.14","first-page":"1","article-title":"The effectiveness and risks of long-term opioid treatment of chronic pain","author":"Chou","year":"2014","journal-title":"Evid Rep Technol Assess"},{"key":"2025120519531241000_10.11.e038724.15","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.732899"},{"key":"2025120519531241000_10.11.e038724.16","unstructured":"Health Professions Act . [RSBC 1996] Chapter 183. Victoria, BC, 2019."},{"key":"2025120519531241000_10.11.e038724.17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11606-002-0037-2","article-title":"The impact of needle exchange-based health services on emergency department use","volume":"17","author":"Pollack","year":"2002","journal-title":"J Gen Intern Med"},{"key":"2025120519531241000_10.11.e038724.18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2016.08.631","article-title":"Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting","volume":"168","author":"Wang","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"2025120519531241000_10.11.e038724.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00411-6"},{"key":"2025120519531241000_10.11.e038724.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00344-7"},{"key":"2025120519531241000_10.11.e038724.21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jsat.2012.03.008","article-title":"Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence","volume":"43","author":"Schwarz","year":"2012","journal-title":"J Subst Abuse Treat"},{"key":"2025120519531241000_10.11.e038724.22","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000188913.50489.77"},{"key":"2025120519531241000_10.11.e038724.23","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000178198.79329.89"},{"key":"2025120519531241000_10.11.e038724.24","first-page":"343","article-title":"Quality of primary care among individuals receiving treatment for opioid use disorder","volume":"65","author":"Spithoff","year":"2019","journal-title":"Can Fam Physician"},{"key":"2025120519531241000_10.11.e038724.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507771"},{"key":"2025120519531241000_10.11.e038724.26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the centers for disease control and prevention opioid guideline: a consensus panel report","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med"},{"key":"2025120519531241000_10.11.e038724.27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/dar.12226","article-title":"Denial of prescription analgesia among people who inject drugs in a Canadian setting","volume":"34","author":"Voon","year":"2015","journal-title":"Drug Alcohol Rev"},{"key":"2025120519531241000_10.11.e038724.28","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170363"},{"key":"2025120519531241000_10.11.e038724.29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drugpo.2019.01.015","article-title":"\u2018Like being put on an ice floe and shoved away\u2019: a qualitative study of the impacts of opioid-related policy changes on people who take opioids","volume":"66","author":"Antoniou","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025120519531241000_10.11.e038724.30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugpo.2019.03.023","article-title":"Chronic pain management among people who use drugs: a health policy challenge in the context of the opioid crisis","volume":"71","author":"Dassieu","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025120519531241000_10.11.e038724.31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/pm\/pny228","article-title":"International Stakeholder community of pain experts and leaders call for an urgent action on forced opioid tapering","volume":"20","author":"Darnall","year":"2019","journal-title":"Pain Medicine"},{"key":"2025120519531241000_10.11.e038724.32","unstructured":"Lupick T . Opioid refugees: How the fentanyl crisis led to a backlash against doctors that\u2019s leaving people in pain. In: The georgia straight. Vancouver, BC, 2018."},{"key":"2025120519531241000_10.11.e038724.33","unstructured":"BC Centre for Disease Control . Overdose response indicators. In: Data & reports. Vancouver, BC: BC Centre for Disease Control, 2019."},{"key":"2025120519531241000_10.11.e038724.34","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1377\/hlthaff.2017.0014","article-title":"In British Columbia, the supply of primary care physicians Grew, but their rate of clinical activity declined","volume":"36","author":"Hedden","year":"2017","journal-title":"Health Aff"},{"key":"2025120519531241000_10.11.e038724.35","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20190003"},{"key":"2025120519531241000_10.11.e038724.36","unstructured":"BC Coroners Service . Illicit drug overdose deaths in bc: findings of coroners\u2019 investigations. Ministry of Public Safety and Solicitor General, 2018."},{"key":"2025120519531241000_10.11.e038724.37","unstructured":"BC Centre for Disease Control . Public health emergency in BC. In Stories. Vancouver, BC: BC Centre for Disease Control, 2017."},{"key":"2025120519531241000_10.11.e038724.38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10742-012-0103-0","article-title":"Joint modeling of multiple longitudinal cost outcomes using multivariate generalized linear mixed models","volume":"13","author":"Gebregziabher","year":"2013","journal-title":"Health Serv Outcomes Res Methodol"},{"key":"2025120519531241000_10.11.e038724.39","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181caeb90"},{"key":"2025120519531241000_10.11.e038724.40","unstructured":"Cook TD . Quasi-experimentation: design analysis issues for field settings. Boston, MA: Houghton Mifflin Company, 1979."},{"key":"2025120519531241000_10.11.e038724.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.02.007"},{"key":"2025120519531241000_10.11.e038724.42","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyy135"},{"key":"2025120519531241000_10.11.e038724.43","first-page":"e231","article-title":"Effects of the new prescribing standards in British Columbia on consumption of opioids and benzodiazepines and z drugs","volume":"65","author":"Crabtree","year":"2019","journal-title":"Can Fam Physician"},{"key":"2025120519531241000_10.11.e038724.44","unstructured":"Pedan A . Analysis of count data using the SAS system. SAS Institute Statistics, Data analysis, and data mining."},{"key":"2025120519531241000_10.11.e038724.45","unstructured":"Liu W , Cela J . Count Data in SAS. SAS Institute statistics and data analysis 2008."},{"key":"2025120519531241000_10.11.e038724.46","unstructured":"Meyer J . Poisson or negative binomial? Using count model diagnostics to select model. In the analysis factor, 2018."},{"key":"2025120519531241000_10.11.e038724.47","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3701"},{"key":"2025120519531241000_10.11.e038724.48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/0962280217720947","article-title":"Competing risks modeling of cumulative effects of time-varying drug exposures","volume":"28","author":"Danieli","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"2025120519531241000_10.11.e038724.49","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.2013.872650"},{"key":"2025120519531241000_10.11.e038724.50","doi-asserted-by":"publisher","DOI":"10.1177\/1479972313482847"},{"key":"2025120519531241000_10.11.e038724.51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065761"},{"key":"2025120519531241000_10.11.e038724.52","first-page":"844","article-title":"Pharmacologic management of chronic neuropathic pain: review of the Canadian pain Society consensus statement","volume":"63","author":"Mu","year":"2017","journal-title":"Can Fam Physician"},{"key":"2025120519531241000_10.11.e038724.53","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-2671(18)30886-4"},{"key":"2025120519531241000_10.11.e038724.54","unstructured":"PopulationDataBC . Data access, 2018. Available: https:\/\/www.popdata.bc.ca\/dataaccess [Accessed 25 Oct 2018]."},{"key":"2025120519531241000_10.11.e038724.55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054496"},{"key":"2025120519531241000_10.11.e038724.56","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1001\/jama.2012.6626","article-title":"Limitations of administrative databases","volume":"307","author":"Haut","year":"2012","journal-title":"JAMA"},{"key":"2025120519531241000_10.11.e038724.57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025120519531241000_10.11.e038724.58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2017.8913","article-title":"New data on opioid use and prescribing in the United StatesNew data on opioid use and prescribing, 2006-2015","volume":"318","author":"Schuchat","year":"2017","journal-title":"JAMA"},{"key":"2025120519531241000_10.11.e038724.59","unstructured":"British Columbia Coroners Service . Illicit drug toxicity deaths in BC: January 1, 2010-June 30, 2020. Victoria, BC: BC Coroners Service, 2020."},{"key":"2025120519531241000_10.11.e038724.60","unstructured":"R\u00e9gie de l\u2019assurance maladie du Qu\u00e9bec . Prescription drug insurance, 2018."},{"key":"2025120519531241000_10.11.e038724.61","unstructured":"R\u00e9gie de l\u2019assurance maladie du Qu\u00e9bec . List of medications, 2018."},{"key":"2025120519531241000_10.11.e038724.62","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/pds.3820","article-title":"Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?","volume":"24","author":"Lacasse","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025120519531241000_10.11.e038724.63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1251"},{"key":"2025120519531241000_10.11.e038724.64","unstructured":"College of Pharmacists of British Columbia . New safety measures for codeine liquid preparations coming soon. Victoria, BC, 2019."},{"key":"2025120519531241000_10.11.e038724.65","first-page":"648","article-title":"Potential misuse and inappropriate prescription practices involving opioid analgesics","volume":"19","author":"Liu","year":"2013","journal-title":"Am J Manag Care"},{"key":"2025120519531241000_10.11.e038724.66","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.13766"},{"key":"2025120519531241000_10.11.e038724.67","unstructured":"College of Pharmacists of British Columbia . Controlled prescription program. Vol. 2018.3. Vancouver, BC, 2018."},{"key":"2025120519531241000_10.11.e038724.68","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20170083"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-038724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:53:22Z","timestamp":1764993202000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-038724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":68,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,5]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bmjopen-2020-038724"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-038724","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}